ReCode Therapeutics Appoints Erica Jefferson as Senior Vice President of Corporate Affairs
Company
ReCode Therapeutics
Menlo ParkBiotechnologyHealthcareHealth CareDescription
ReCode Therapeutics, a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today the appointment of Erica Jefferson as senior vice president of corporate affairs. In this newly created role, Ms. Jefferson will be responsible for the strategic leadership, development, and management of ReCode’s external and employee communications initiatives, including media, investor, and stakeholder engagement
Who to call at ReCode Therapeutics, and when
A new leader at ReCode Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day ReCode Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ReCode Therapeutics, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ReCode Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ReCode Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.